发明名称 |
CRISPR-BASED GENOME MODIFICATION AND REGULATION |
摘要 |
The present invention provides RNA-guided endonucleases, which are engineered for expression in eukaryotic cells or embryos, and methods of using the RNA-guided endonuclease for targeted genome modification in in eukaryotic cells or embryos. Also provided are fusion proteins, wherein each fusion protein comprises a CRISPR/Cas-like protein or fragment thereof and an effector domain. The effector domain can be a cleavage domain, an epigenetic modification domain, a transcriptional activation domain, or a transcriptional repressor domain. Also provided are methods for using the fusion proteins to modify a chromosomal sequence or regulate expression of a chromosomal sequence. |
申请公布号 |
US2017073705(A1) |
申请公布日期 |
2017.03.16 |
申请号 |
US201615342976 |
申请日期 |
2016.11.03 |
申请人 |
SIGMA-ALDRICH CO. LLC |
发明人 |
CHEN Fuqiang;DAVIS Gregory D.;KANG Qiaohua;KNIGHT Scott W. |
分类号 |
C12N15/90;C12N9/22 |
主分类号 |
C12N15/90 |
代理机构 |
|
代理人 |
|
主权项 |
1. An isolated endonuclease comprising at least one nuclear localization signal, at least one nuclease domain, and at least one domain that interacts with a guide RNA to target the endonuclease to a specific nucleotide sequence for cleavage. |
地址 |
St. Louis MO US |